AU Stock MarketDetailed Quotes

MXCDA MGC Pharmaceuticals Ltd

Watchlist

0.475
0.0000.00%

20min DelayMarket Closed Nov 7 16:00 AET

2.10MMarket Cap-66P/E (Static)

MGC Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Assets

Current assets

Cash, cash equivalents and short term investments

-86.58%239.82K

--239.82K

-67.11%1.79M

190.02%5.43M

-20.42%1.87M

--2.35M

-Cash and cash equivalents

-86.58%239.82K

--239.82K

-67.11%1.79M

190.02%5.43M

-20.42%1.87M

--2.35M

-Accounts receivable

-72.94%208.74K

--208.74K

-8.25%771.54K

--840.96K

----

--271.02K

-Other receivables

67.84%1.12M

--1.12M

16.05%666.21K

--574.09K

----

--428.89K

Holding assets for sale

----

-22.66%280.48K

--362.66K

----

Total current assets

-67.01%2.43M

--2.43M

-22.39%7.36M

193.45%9.48M

-13.15%3.23M

--3.72M

Non current assets

-Accumulated depreciation

-25.77%-1.82M

---1.82M

-31.22%-1.45M

---1.11M

----

---572.01K

-Long term equity investment

-82.06%384.57K

--384.57K

20.86%2.14M

-3.90%1.77M

--1.85M

----

-Goodwill

----

-23.62%5.38M

--7.05M

----

--5.03M

Regulatory assets

-84.13%531.31K

--531.31K

42.53%3.35M

476.93%2.35M

-64.29%407.09K

--1.14M

Liabilities

Current liabilities

Current debt and capital lease obligation

26.10%190.57K

--190.57K

-96.92%151.12K

8,986.80%4.9M

--53.92K

----

-Current debt

----

--4.69M

----

-Current capital lease obligation

26.10%190.57K

--190.57K

-27.84%151.12K

288.39%209.43K

--53.92K

----

-accounts payable

-12.67%2.19M

--2.19M

104.79%2.5M

-54.83%1.22M

132.30%2.71M

--1.16M

-Total tax payable

5.12%4.76M

--4.76M

5.74%4.53M

129.44%4.28M

10,747.82%1.87M

--17.2K

-Other payable

----

-16.26%564.19K

-75.69%673.74K

--2.77M

Current deferred liabilities

-57.67%584.61K

--584.61K

--1.38M

----

-82.91%100.44K

--587.69K

Current liabilities

88.89%13.26M

--13.26M

-36.11%7.02M

269.96%10.99M

36.13%2.97M

--2.18M

Non current liabilities

-Long term debt

-82.06%384.57K

--384.57K

20.86%2.14M

-3.90%1.77M

--1.85M

----

Non current accrued expenses

-23.18%7.45M

--7.45M

35.86%9.7M

77.45%7.14M

173.68%4.02M

--1.47M

Regulatory liabilities

----

---547K

----

Total non current liabilities

56.05%18.02M

--18.02M

-24.37%11.54M

215.75%15.27M

119.90%4.83M

--2.2M

Shareholders'equity

Share capital

6.44%103.71M

--103.71M

25.32%97.44M

29.26%77.75M

22.42%60.15M

--49.13M

-common stock

6.44%103.71M

--103.71M

25.32%97.44M

29.26%77.75M

22.42%60.15M

--49.13M

Gains losses not affecting retained earnings

-11.05%7.95M

--7.95M

22.13%8.94M

44.00%7.32M

54.51%5.08M

--3.29M

Total equity

-56.28%9.88M

--9.88M

-6.75%22.6M

205.66%24.24M

-38.99%7.93M

--13M

	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments	-86.58%239.82K	--239.82K	-67.11%1.79M	190.02%5.43M	-20.42%1.87M	--2.35M
-Cash and cash equivalents	-86.58%239.82K	--239.82K	-67.11%1.79M	190.02%5.43M	-20.42%1.87M	--2.35M
-Accounts receivable	-72.94%208.74K	--208.74K	-8.25%771.54K	--840.96K	----	--271.02K
-Other receivables	67.84%1.12M	--1.12M	16.05%666.21K	--574.09K	----	--428.89K
Holding assets for sale	----	----	----	-22.66%280.48K	--362.66K	----
Total current assets	-67.01%2.43M	--2.43M	-22.39%7.36M	193.45%9.48M	-13.15%3.23M	--3.72M
Non current assets
-Accumulated depreciation	-25.77%-1.82M	---1.82M	-31.22%-1.45M	---1.11M	----	---572.01K
-Long term equity investment	-82.06%384.57K	--384.57K	20.86%2.14M	-3.90%1.77M	--1.85M	----
-Goodwill	----	----	-23.62%5.38M	--7.05M	----	--5.03M
Regulatory assets	-84.13%531.31K	--531.31K	42.53%3.35M	476.93%2.35M	-64.29%407.09K	--1.14M
Liabilities
Current liabilities
Current debt and capital lease obligation	26.10%190.57K	--190.57K	-96.92%151.12K	8,986.80%4.9M	--53.92K	----
-Current debt	----	----	----	--4.69M	----	----
-Current capital lease obligation	26.10%190.57K	--190.57K	-27.84%151.12K	288.39%209.43K	--53.92K	----
-accounts payable	-12.67%2.19M	--2.19M	104.79%2.5M	-54.83%1.22M	132.30%2.71M	--1.16M
-Total tax payable	5.12%4.76M	--4.76M	5.74%4.53M	129.44%4.28M	10,747.82%1.87M	--17.2K
-Other payable	----	----	----	-16.26%564.19K	-75.69%673.74K	--2.77M
Current deferred liabilities	-57.67%584.61K	--584.61K	--1.38M	----	-82.91%100.44K	--587.69K
Current liabilities	88.89%13.26M	--13.26M	-36.11%7.02M	269.96%10.99M	36.13%2.97M	--2.18M
Non current liabilities
-Long term debt	-82.06%384.57K	--384.57K	20.86%2.14M	-3.90%1.77M	--1.85M	----
Non current accrued expenses	-23.18%7.45M	--7.45M	35.86%9.7M	77.45%7.14M	173.68%4.02M	--1.47M
Regulatory liabilities	----	----	----	---547K	----	----
Total non current liabilities	56.05%18.02M	--18.02M	-24.37%11.54M	215.75%15.27M	119.90%4.83M	--2.2M
Shareholders'equity
Share capital	6.44%103.71M	--103.71M	25.32%97.44M	29.26%77.75M	22.42%60.15M	--49.13M
-common stock	6.44%103.71M	--103.71M	25.32%97.44M	29.26%77.75M	22.42%60.15M	--49.13M
Gains losses not affecting retained earnings	-11.05%7.95M	--7.95M	22.13%8.94M	44.00%7.32M	54.51%5.08M	--3.29M
Total equity	-56.28%9.88M	--9.88M	-6.75%22.6M	205.66%24.24M	-38.99%7.93M	--13M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall